ORIC Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US68622P1093

SecurityORIC / ORIC Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership2,422,741 shares
Latest Disclosed Value $ 30,696,128
Citadel Advisors Llc ownership in ORIC / ORIC Pharmaceuticals, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 2,422,741 shares of ORIC Pharmaceuticals, Inc. (US:ORIC) valued at $30,696,128 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,434,710 shares of ORIC Pharmaceuticals, Inc.. This represents a change in shares of -0.49% during the quarter. The current value of the position is $18,170,558 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (ORIC) in the form of stock options. The firm currently holds call options representing 10,000 of underlying shares valued at $126,700 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ORIC / ORIC Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 2,422,741 -11,969 -0.49 30,696 54.14 0.0050
2026-02-17 2025-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 2,434,710 1,236,706 103.23 19,916 38.53 0.0030
2025-11-14 2025-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 1,198,004 -204,764 -14.60 14,376 0.97 0.0022
2025-08-14 2025-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 1,402,768 890,879 174.04 14,238 398.53 0.0025
2025-05-15 2025-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 511,889 475,463 1,305.28 2,856 874.74 0.0005
2025-02-14 2024-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 36,426 30,659 531.63 294 396.61 0.0001
2024-11-14 2024-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 5,767 5,767 59 0.0000
2024-02-14 2023-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 0 -145,007 -100.00 0 -100.00
2023-11-14 2023-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 145,007 66,732 85.25 877 44.48 0.0002
2023-08-14 2023-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 78,275 -41,328 -34.55 607 -10.87 0.0001
2023-05-15 2023-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 119,603 40,970 52.10 682 47.08 0.0001
2023-02-14 2022-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 78,633 66,196 532.25 463 1,057.50 0.0001
2022-11-14 2022-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 12,437 -187,950 -93.79 40 -95.55 0.0000
2022-08-15 2022-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 200,387 -30,300 -13.13 898 -27.11 0.0002
2022-05-16 2022-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 230,687 230,687 1,232 0.0003
2022-02-14 2021-12-31 13F ORIC PHARMACEUTICALS Cmn 68622P109 0 -15,377 -100.00 0 -100.00
2021-11-15 2021-09-30 13F ORIC PHARMACEUTICALS Cmn 68622P109 15,377 -3,938 -20.39 322 -5.85 0.0001
2021-08-16 2021-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 19,315 19,315 342 0.0001
2021-05-21 2021-03-31 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 0 -40,435 -100.00 0 -100.00
2021-02-16 2020-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 40,435 -26,772 -39.84 1,369 -18.56 0.0004
2020-11-16 2020-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 67,207 60,376 883.85 1,681 630.87 0.0005
2020-08-14 2020-06-30 13F ORIC PHARMACEUTICALS Cmn 68622P109 6,831 6,831 230 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ORIC PHARMACEUTICALS COM Call 10,000 -32.89 127 4.13 n/a n/a n/a
2026-02-17 2025-12-31 13F ORIC PHARMACEUTICALS COM Call 14,900 -32.58 122 -54.34 n/a n/a n/a
2025-11-14 2025-09-30 13F ORIC PHARMACEUTICALS COM Call 22,100 0.91 265 19.37 n/a n/a n/a
2025-08-14 2025-06-30 13F ORIC PHARMACEUTICALS COM Call 21,900 93.81 222 252.38 n/a n/a n/a
2025-05-15 2025-03-31 13F ORIC PHARMACEUTICALS COM Call 11,300 135.42 63 65.79 n/a n/a n/a
2025-02-14 2024-12-31 13F ORIC PHARMACEUTICALS COM Call 4,800 -38.46 39 -51.90 n/a n/a n/a
2024-11-14 2024-09-30 13F ORIC PHARMACEUTICALS COM Call 7,800 80 n/a n/a n/a
2024-08-14 2024-06-30 13F ORIC PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ORIC PHARMACEUTICALS COM Call 22,200 305 n/a n/a n/a
2024-02-14 2023-12-31 13F ORIC PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F ORIC PHARMACEUTICALS COM Call 4,400 -53.19 27 -63.89 n/a n/a n/a
2023-08-14 2023-06-30 13F ORIC PHARMACEUTICALS COM Call 9,400 18.99 73 60.00 n/a n/a n/a
2023-05-15 2023-03-31 13F ORIC PHARMACEUTICALS COM Call 7,900 -83.68 45 -84.21 n/a n/a n/a
2023-02-14 2022-12-31 13F ORIC PHARMACEUTICALS COM Call 48,400 -73.61 285 -51.45 n/a n/a n/a
2022-11-14 2022-09-30 13F ORIC PHARMACEUTICALS COM Call 183,400 -40.55 587 -57.53 n/a n/a n/a
2022-08-15 2022-06-30 13F ORIC PHARMACEUTICALS COM Call 308,500 87.20 1,382 57.05 n/a n/a n/a
2022-05-16 2022-03-31 13F ORIC PHARMACEUTICALS COM Call 164,800 880 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-14 2025-06-30 13F ORIC PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F ORIC PHARMACEUTICALS COM Put 2,700 -57.81 15 -70.59 n/a n/a n/a
2025-02-14 2024-12-31 13F ORIC PHARMACEUTICALS COM Put 6,400 814.29 52 628.57 n/a n/a n/a
2024-11-14 2024-09-30 13F ORIC PHARMACEUTICALS COM Put 700 7 n/a n/a n/a
2024-08-14 2024-06-30 13F ORIC PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ORIC PHARMACEUTICALS COM Put 7,700 106 n/a n/a n/a
2023-11-14 2023-09-30 13F ORIC PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F ORIC PHARMACEUTICALS COM Put 1,800 -75.68 14 -69.05 n/a n/a n/a
2023-05-15 2023-03-31 13F ORIC PHARMACEUTICALS COM Put 7,400 54.17 42 50.00 n/a n/a n/a
2023-02-14 2022-12-31 13F ORIC PHARMACEUTICALS COM Put 4,800 -76.81 28 -57.58 n/a n/a n/a
2022-11-14 2022-09-30 13F ORIC PHARMACEUTICALS COM Put 20,700 -7.59 66 -34.00 n/a n/a n/a
2022-08-15 2022-06-30 13F ORIC PHARMACEUTICALS COM Put 22,400 100 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.